Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesWomens ImagingAI spots breast lesions on targeted ultrasoundCombining AI with radiologist interpretation can improve breast lesion detection on targeted ultrasound.MRIMRI supplies answers in complex cases of brain metastasesMRIMRI reveals effects of ultraprocessed food on the heartArtificial IntelligenceDutch team pinpoints key trends in radiology AICTVicky Goh: We need better risk stratification of colon cancer